Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study

Jeffrey L. Cummings, Barbara Koumaras, Michael Chen, Dario Mirski, Ellen Binder, Marshal Folstein, Elsa M. Zayas, Raymond Ownby, Charles H. Merideth, Douglas W. Scharre, Pierre Tariot, Keith Edwards, Peter M. Aupperle, Jay M. Ellis, Jorg J. Pahl, Ari Kiev

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences